Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05626426 · ClinicalTrials.gov registry record · NA

Electrical Stimulation for the Treatment of Optic Neuropathies

A NA study of Glaucoma and Glaucoma Open-Angle, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05626426 is a NA study of Glaucoma and Glaucoma Open-Angle that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05626426, a NA study of Glaucoma and Glaucoma Open-Angle, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.

Interventions

  • DEVICE Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Study Locations (1)

California

  • Byers Eye Institute - Palo Alto

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-02-27
Est. Completion 2027-12
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05626426

The ClinicalTrials.gov registry entry for NCT05626426 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Repetitive, Transorbital Alternating Current Stimulation (rtACS) is the first listed.

NCT05626426 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05626426 about?

NCT05626426 is a clinical study titled "Electrical Stimulation for the Treatment of Optic Neuropathies". The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your e...

What is the current status of trial NCT05626426?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-02-27. Estimated completion is 2027-12.

What conditions does trial NCT05626426 study?

This clinical trial studies the following conditions: Glaucoma, Glaucoma Open-Angle, Optic Nerve Diseases.

What interventions are being tested in trial NCT05626426?

The interventions under investigation include: Repetitive, Transorbital Alternating Current Stimulation (rtACS) (DEVICE).

Who is sponsoring clinical trial NCT05626426?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05626426 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.